Advertisement

Ads Placeholder
Loading...

Aurora Cannabis Inc.

ACB•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.44
$0.09(2.69%)
U.S. Market opens in 0h 56m

Aurora Cannabis Inc. (ACB) Stock Overview

Explore Aurora Cannabis Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap195.1M
P/E Ratio-6.39
EPS (TTM)$-1.07
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$2.71
3 Months$5.12
1 Year Target$5.25

ACB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aurora Cannabis Inc. (ACB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.39 and a market capitalization of 195.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.69%
5-Day Change
3.93%
1-Month Change
-1.15%
3-Month Change
-20.74%
6-Month Change
-39.12%
Year-to-Date (YTD) Change
-20.74%
1-Year Change
-19.81%
3-Year Change
-48.66%
5-Year Change
-96.24%
All-Time (Max) Change
-96.82%

Contact Information

https://www.auroramj.com
16043625207
500 - 10355 Jasper Avenue, Edmonton, AB, T5J 1Y6

Company Facts

10,730 Employees
IPO DateJul 15, 2014
CountryCA
Actively Trading

Frequently Asked Questions